Development of evidence-based vaccination guidelines for infectious disease prevention on large passenger ships
More details
Hide details
1
Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, Larissa, Greece
2
Healthy Sailing Project, Greece
3
National Centre of Epidemiology, Carlos III Health Institute, Madrid, Spain
4
CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain
5
Liguria Health Port Authority (USMAF), Genova, Italy
6
Ministry of Health, Italy
7
EU SHIPSAN Association, Larissa, Greece
Publication date: 2025-12-05
Popul. Med. 2025;7(Supplement 1):A14
KEYWORDS
ABSTRACT
Introduction:
Infectious diseases might pose a significant risk to public health in maritime settings, particularly on large passenger ships, where close contact and shared spaces heighten the potential for outbreaks, if control measures are not in place. Task 3.7.2, a part of the EU Healthy Sailing initiative, aims to develop evidence-based vaccination guidelines to prevent vaccine preventable diseases.
Methods:
A comprehensive review of existing ship operational frameworks good practices, literature and guidelines from organizations including WHO, IMO, ECDC, and EMSA was conducted. A questionnaire was sent to four cruise lines and one ferry line to gather information on current vaccination practices. The extracted data was categorized as follows:
1) Vaccine recommendations from WHO for travelers and occupational groups relevant to passenger ships
2) Vaccine recommendations for crew and passengers
3) Timing of the vaccination:
a) as a condition of employment (for crew)
b) before travelling at any destination (for passengers)
c) before travelling at certain destination (for passengers and crew)
d) as part of outbreak management
4) Prioritization scale 1-5
Expert opinions and input from target groups, including the cruise and ferry industries, have been gathered to ensure the guidelines' relevance and practicality. The task drew on outcomes from related Healthy Sailing tasks and lessons learned from previous outbreaks like COVID-19.
Results:
Two of the five companies have shared guidelines, and data collection is ongoing. Vaccination strategies were categorized by ship and voyage type. The working group is developing a list of vaccine-preventable diseases for potential inclusion, with special focus on crew and passengers traveling to endemic regions, recommendations will be tailored to specific crew departments and positions.
Conclusions:
The developed guidelines will offer an evidence-based framework for vaccination on large passenger ships, aligning with international standards to enhance maritime health safety. Pilot testing on operational vessels will assess their practicality, with feedback from operators and authorities incorporated into the final version.
ACKNOWLEDGEMENTS
: The authors would like to thank the HEALTHY SAILING project team and all stakeholders who provided valuable input during the development of the guidelines.
CONFLICTS OF INTEREST
FUNDING
HEALTHY SAILING project has received funding from the European Union’s Horizon Europe Framework Programme (HORIZON) under Grant Agreement number 101069764. Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Climate, Infrastructure and Environment Executive Agency (CINEA). Neither the European Union nor the granting authority can be held responsible for them. This work was funded by UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee [grant number 10040786], [grant number 10040720]. This work has received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI).
ETHICAL APPROVAL AND INFORMED CONSENT
The HEALTHY SAILING project study has received approval from the University of Thessaly Research Ethics Committee for implementing Healthy Sailing research protocols.
Approval committee: University of Thessaly Research Ethics Committee
Full approval date: 19.09.2022
Approval number: 59 / 19.09.2022
REFERENCES (5)
1.
Mouchtouri V, Lewis H, Hadjichristodoulou C. A systematic review for vaccine-preventable diseases on ships: evidence for cross-border transmission and for pre-employment immunization need. Int J Environ Res Public Health. 2019;16(15):2713. doi:10.3390/ijerph16152713.
2.
World Health Organization. International travel and health: Chapter 6 - Vaccine-preventable diseases and vaccines. Updated 2019. Published 2019. Accessed October 15, 2024.
https://cdn.who.int/media/docs....
3.
EU HEALTHY GATEWAYS Joint Action. Outbreak Management of COVID-19 in Cruise Ships: Guidelines for Management of Suspected Cases of COVID-19 and Contacts. Published June 2022. Accessed October 15, 2024.
https://www.healthygateways.eu....
4.
Mouchtouri VA, Anagnostopoulos L, Kourentis L, et al. EU Healthy Sailing Guidelines for the Prevention, Mitigation and Management of COVID-19 on Board Large Passenger Vessels (Interim Version). EU HEALTHY GATEWAYS Joint Action, produced under sub-task 3.7.1.
5.
Centers for Disease Control and Prevention. CDC Yellow Book 2024: Health Information for International Travel. Accessed October 15, 2024.
https://wwwnc.cdc.gov/travel/p....